3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
8
Lymphoid
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
17
Lung Neoplasms
6
Head and Neck Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Kidney Neoplasms
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Skin Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Sezary Syndrome
2
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Cyclophosphamide
6
pembrolizumab
3
Filgrastim
3
fludarabine
2
Nivolumab
2
Mesna
2
Ipilimumab
2
Ifosfamide
2
Gemcitabine
2
Etoposide
2
Docetaxel
2
Cryosurgery
2
Carboplatin
2
tocilizumab
1
tipifarnib
1
tanespimycin
1
poly ICLC
1
montanide ISA 51
1
lorukafusp alfa
1
humanized 3F8 anti-GD2 monoclonal antibody
1
fludarabine phosphate
1
flt3 ligand protein
1
entinostat
1
dostarlimab
1
cc-486
1
X-Rays
1
Thrombopoietin
1
Therapeutics
1
Thalidomide
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Drug Therapy
×
Dermatologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled